1 2 3 4 5

O-011 Low-dose IL-2 Administration Expands Human Regulatory T Cells in Patients with UC and Humanized Mice and Protects Against Experimental Colitis.

Goettel, Jeremy; Kotlarz, Daniel; Illig, David; More

Inflammatory Bowel Diseases . 23():S4, February 2017.

P-312 Mucosal Gene Expression in Pediatric and Adult Patients with Ulcerative Colitis Permits Modeling of Ideal Biopsy Collection for Transcriptomic Analysis.

Ouahed, Jodie; Gordon, William; Canavan, James; More

Inflammatory Bowel Diseases . 23():S99-S100, February 2017.

P-108 Infliximab-Associated Suppression of Cytokine Release by Mucosal Explants Predicts Success of Anti-TNF Therapy in Patients with Inflammatory Bowel Disease.

Otsubo, Takeshi; Alsahwi, Nassib; Wahed, Renaisa; More

Inflammatory Bowel Diseases . 22():S43-S44, March 2016.

Prevalence of Inflammatory Bowel Disease Among Patients with Autism Spectrum Disorders

Doshi-Velez, Finale; Avillach, Paul; Palmer, Nathan; More

Inflammatory Bowel Diseases . 21(10):2281-2288, October 2015.

Effect of 2 Psychotherapies on Depression and Disease Activity in Pediatric Crohn's Disease

Szigethy, Eva; Youk, Ada O.; Gonzalez-Heydrich, Joseph; More

Inflammatory Bowel Diseases . 21(6):1321-1328, June 2015.

Antibodies to Infliximab Are Associated with Lower Infliximab Levels and Increased Likelihood of Surgery in Pediatric IBD

Zitomersky, Naamah L.; Atkinson, Benjamin J.; Fournier, Kerri; More

Inflammatory Bowel Diseases . 21(2):307-314, February 2015.

Predictors of Abdominal Pain in Depressed Pediatric Inflammatory Bowel Disease Patients

Srinath, Arvind I.; Goyal, Alka; Zimmerman, Lori A.; More

Inflammatory Bowel Diseases . 20(8):1329-1340, August 2014.

Immunogenicity and Tolerability to Human Papillomavirus-like Particle Vaccine in Girls and Young Women with Inflammatory Bowel Disease

Jacobson, Denise L.; Bousvaros, Athos; Ashworth, Lori; More

Inflammatory Bowel Diseases . 19(7):1441-1449, June 2013.

Appraisal of the pediatric ulcerative colitis activity index (PUCAI)

Turner, Dan; Hyams, Jeffrey; Markowitz, James; More

Inflammatory Bowel Diseases . 15(8):1218-1223, August 2009.

Long‐term outcome of maintenance infliximab therapy in children with Crohn's disease

Hyams, Jeffrey S.; Lerer, Trudy; Griffiths, Anne; More

Inflammatory Bowel Diseases . 15(6):816-822, June 2009.

Course and Treatment of Perianal Disease in Children Newly Diagnosed with Crohn's Disease

Keljo, David J.; Markowitz, James; Langton, Christine; More

Inflammatory Bowel Diseases . 15(3):383-387, March 2009.

Effect of early immunomodulator use in moderate to severe pediatric Crohn disease

Punati, Jaya; Markowitz, James; Lerer, Trudy; More

Inflammatory Bowel Diseases . 14(7):949-954, July 2008.

Intercenter variation in initial management of children with Crohn's disease

Kappelman, Michael D.; Bousvaros, Athos; Hyams, Jeffrey; More

Inflammatory Bowel Diseases . 13(7):890-895, July 2007.

Challenges in pediatric inflammatory bowel disease

Bousvaros, Athos; Sylvester, Francisco; Kugathasan, Subra; More

Inflammatory Bowel Diseases . 12(9):885-913, September 2006.

Health‐related quality of life in the first year after a diagnosis of pediatric inflammatory bowel disease

Otley, Anthony R.; Griffiths, Anne M.; Hale, Sandra; More

Inflammatory Bowel Diseases . 12(8):684-691, August 2006.

5‐Aminosalicylate therapy is associated with higher 6‐thioguanine levels in adults and children with inflammatory bowel disease in remission on 6‐mercaptopurine or azathioprine

Hande, Scott; Wilson-Rich, Noah; Bousvaros, Athos; More

Inflammatory Bowel Diseases . 12(4):251-257, April 2006.

A Randomized, Double‐blind Trial of Lactobacillus GG Versus Placebo in Addition to Standard Maintenance Therapy for Children with Crohn's Disease

Bousvaros, Athos; Guandalini, Stefano; Baldassano, Robert N; More

Inflammatory Bowel Diseases . 11(9):833-839, September 2005.

1 2 3 4 5